Current trends in bladder cancer treatment.
Lamm
D L
DL
West Virginia University, Department of Urology, Morgantown 26505, USA.
Allaway
M
M
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D015331:Cohort Studies; D015653:Cystectomy; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D005737:Garlic / Q000627:therapeutic use; D015316:Genetic Therapy; D006801:Humans; D016233:Immunotherapy, Active; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D008517:Phytotherapy; D010946:Plants, Medicinal; D011446:Prospective Studies; D011736:Pyridoxine / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D009626:Terminology as Topic; D013997:Time Factors; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D014547:Urinary Diversion; D014801:Vitamin A / Q000627:therapeutic use
D014801:Vitamin A; D011736:Pyridoxine; D001205:Ascorbic Acid